ANABVAnaptysBio Inc - When Issued - April 2026

$43.80
$0.80
(1.86%)
Today
Updated: 03:59 PM EDT
Vol2,077.00

About

AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. It also offers SHM platform that replicate the natural process of somatic hypermutation embedded within the human immune system to rapidly develop a diverse range of therapeutic-grade antibodies in vitro. The company was founded by Andrew B. Cubitt, William J. Boyle, Kevin J. Kinsella, and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is the 52-week high for AnaptysBio Inc - When Issued - April 2026?
What is the 52-week low for AnaptysBio Inc - When Issued - April 2026?
What is AnaptysBio Inc - When Issued - April 2026 stock price today?
What was AnaptysBio Inc - When Issued - April 2026 stock price yesterday?
What is the 50-day moving average of AnaptysBio Inc - When Issued - April 2026?

Advertisement|Remove ads.